Pre-earnings options volume in Annexon is normal with calls leading puts 19:5. Implied volatility suggests the market is anticipating a move near 8.2%, or 40c, after results are released. Median move over the past eight quarters is 4.1%.
Protect Your Portfolio Against Market Uncertainty
- Discover companies with rock-solid fundamentals in TipRanks' Smart Value Newsletter.
- Receive undervalued stocks, resilient to market uncertainty, delivered straight to your inbox.
Published first on TheFly – the ultimate source for real-time, market-moving breaking financial news. Try Now>>
Read More on ANNX:
- Annexon Reports First Quarter 2024 Financial Results and Key Anticipated Milestones
- Annexon Biosciences to Present at the Bank of America Health Care Conference
- Annexon Presents New Neuroprotection Data Showing ANX007 Protects Vision and Vision-Associated Structures in Geographic Atrophy at ARVO 2024 Annual Meeting
- Annexon Biosciences, Inc. (ANNX) Q1 Earnings Cheat Sheet
- Annexon Reports Inducement Grants to New Employees Under Nasdaq Listing Rule 5635(c)(4)